168 related articles for article (PubMed ID: 15507296)
21. Antiphospholipid antibodies--our experience.
Srikrishna A; Sitalakshmi S; Devi S; Damodar P; Varghese J; Suresh J; Mathew T
Indian J Pathol Microbiol; 2004 Apr; 47(2):174-7. PubMed ID: 16295461
[TBL] [Abstract][Full Text] [Related]
22. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
To CH; Petri M
Arthritis Rheum; 2005 Dec; 52(12):4003-10. PubMed ID: 16320348
[TBL] [Abstract][Full Text] [Related]
23. Study of antiphospholipid antibodies in patients treated with antiepileptic drugs.
Pardo A; González-Porque P; Gobernado JM; Jiménez-Escrig A; Lousa M
Neurologia; 2001 Jan; 16(1):7-10. PubMed ID: 11234666
[TBL] [Abstract][Full Text] [Related]
24. Intima-media thickness measurement of the carotid artery in patients with primary hyperparathyroidism. A prospective case-control study and long-term follow-up.
Lumachi F; Ermani M; Frego M; Pilon F; Filosa T; Di Cristofaro L; De Lotto F; Fallo F
In Vivo; 2006; 20(6B):887-90. PubMed ID: 17203784
[TBL] [Abstract][Full Text] [Related]
25. The risk for thromboembolic disease in lupus anticoagulant patients due to pathways involving P-selectin and CD154.
Bugert P; Pabinger I; Stamer K; Vormittag R; Skeate RC; Wahi MM; Panzer S
Thromb Haemost; 2007 Apr; 97(4):573-80. PubMed ID: 17393020
[TBL] [Abstract][Full Text] [Related]
26. [Incidence of selected antiphospholipid antibodies in a group of patients with systemic lupus erythematosus].
Fojtík Z; Beránek M; Klabusay M; Korístek Z; Buliková A
Vnitr Lek; 2004 Apr; 50(4):267-73. PubMed ID: 15214295
[TBL] [Abstract][Full Text] [Related]
27. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population.
Lambert M; Ferrard-Sasson G; Dubucquoi S; Hachulla E; Prin L; Hatron PY; Goudemand J; Boffa MC; Caron C
Thromb Haemost; 2009 Mar; 101(3):577-81. PubMed ID: 19277423
[TBL] [Abstract][Full Text] [Related]
28. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
29. Predictors of carotid atherosclerosis in systemic lupus erythematosus.
Maksimowicz-McKinnon K; Magder LS; Petri M
J Rheumatol; 2006 Dec; 33(12):2458-63. PubMed ID: 17014002
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
31. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
32. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.
Afeltra A; Vadacca M; Conti L; Galluzzo S; Mitterhofer AP; Ferri GM; Del Porto F; Caccavo D; Gandolfo GM; Amoroso A
Arthritis Rheum; 2005 Jun; 53(3):452-9. PubMed ID: 15934123
[TBL] [Abstract][Full Text] [Related]
33. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.
Sanmarco M; Gayet S; Alessi MC; Audrain M; de Maistre E; Gris JC; de Groot PG; Hachulla E; Harlé JR; Sié P; Boffa MC
Thromb Haemost; 2007 Jun; 97(6):949-54. PubMed ID: 17549297
[TBL] [Abstract][Full Text] [Related]
34. The association of antiphospholipid antibodies with ischaemic stroke and myocardial infarction in young and their correlation: a preliminary study.
Singh K; Gaiha M; Shome DK; Gupta VK; Anuradha S
J Assoc Physicians India; 2001 May; 49():527-9. PubMed ID: 11361266
[TBL] [Abstract][Full Text] [Related]
35. The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile.
Galli M; Finazzi G; Norbis F; Marziali S; Marchioli R; Barbui T
Thromb Haemost; 1999 May; 81(5):695-700. PubMed ID: 10365739
[TBL] [Abstract][Full Text] [Related]
36. [The positive rate of lupus anticoagulant according to the each understanding disease in our hospital].
Omote M; Yoshida T; Asakura H; Ontachi Y; Hayashi T; Morishita E; Yamazaki M; Fujita S; Nakao S
Rinsho Byori; 2006 Sep; 54(9):903-9. PubMed ID: 17063871
[TBL] [Abstract][Full Text] [Related]
37. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.
Mangili A; Gerrior J; Tang AM; O'Leary DH; Polak JK; Schaefer EJ; Gorbach SL; Wanke CA
Clin Infect Dis; 2006 Dec; 43(11):1482-9. PubMed ID: 17083026
[TBL] [Abstract][Full Text] [Related]
38. Detecting anti-prothrombin antibodies in young women with acute ischemic stroke.
Cojocaru IM; Cojocaru M; Tănăsescu R; Burcin C; Mitu AC; Iliescu I; Dumitrescu L; Pavel I; Silosi I
Rom J Intern Med; 2008; 46(4):337-41. PubMed ID: 19480300
[TBL] [Abstract][Full Text] [Related]
39. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
Rodriguez VE; Gonzalez-Pares EN; Rivera C
P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
[TBL] [Abstract][Full Text] [Related]
40. Morbidity of lupus anticoagulants in children: a single institution experience.
Casais P; Meschengieser SS; Gennari LC; Alberto MF; Sanchez-Luceros A; Blanco AN; Lazzari MA
Thromb Res; 2004; 114(4):245-9. PubMed ID: 15381387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
